atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
Location: Belgium, Luxembourg, Marche-en-Famenne
Employees: 11-50
Total raised: $57.22M
Investors 2
| Date | Name | Website |
| 26.12.2024 | MRL Ventur... | mrlv.com |
| 05.07.2025 | SFPIM | sfpim.be |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.11.2024 | Series A | $57.22M | - |
Mentions in press and media 6
| Date | Title | Description |
| 19.11.2024 | ATB Therapeutics Secures €54 Million to Revolutionize Antibody Treatments | In a bold move that could reshape the landscape of biopharmaceuticals, ATB Therapeutics has successfully raised €54 million in a Series A funding round. This financing, led by EQT Life Sciences and MRL Ventures Fund, marks a significant mil... |
| 19.11.2024 | ATB Therapeutics: Biologics Company Raises €54 Million (Series A) | EQT Life Sciences announced that its LSP 7 fund has invested in ATB Therapeutics. The €54 million Series A funding round aims to accelerate the clinical development of a therapeutic antibody pipeline derived from its proprietary ATBioFarm p... |
| 18.11.2024 | ATB Therapeutics Raises €54M in Series A Funding | ATB Therapeutics, an Aye, Belgium-based company developing therapeutic antibody pipeline derived from its proprietary ATBioFarm platform, raised €54M in Series A funding. The round was led by EQT Life Sciences through its LSP 7 fund and MRL... |
| 18.11.2024 | EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics | EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics Mon, Nov 18, 2024 16:15 CET Report this content Proceeds will fund clinical development of oncology and immunology therapeutics derived from innovative antibody payl... |
| 05.08.2023 | Revolutionizing Healthcare: Belgium’s 15 Innovative Startups | Belgium’s healthcare landscape is experiencing a remarkable transformation, thanks to a wave of innovative startups that are revolutionizing the industry. From advanced therapeutics to smart living technology and personalized care solutions... |
| - | ATB Therapeutics | “ATB Therapeutics” |